EP 0092385 B1 19910612 - HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS
Title (en)
HYDANTOIN DERIVATIVES FOR USE IN INHIBITING ALDOSE REDUCTASE ACTIVITY, COMPOSITIONS THEREFOR AND PROCESS FOR PREPARING SPIRO-FLUOREN COMPOUNDS
Publication
Application
Priority
- US 36863082 A 19820415
- US 36863182 A 19820415
- US 36863282 A 19820415
Abstract (en)
[origin: EP0092385A2] Inhibition of aldose reductase activity with tetracyclic spiro-hydantoins, new tetracyclic spirohydantoin derivatives useful in the treatment of complications arising from diabetes mellitus, and a process for preparing spiro-imidazolidine-diones by reacting a mono- or di-fluorofluorene with an excess of oxygen and a tetralkyl- or arylalkyl-trialkyl-ammonium hydroxide are disclosed.
IPC 1-7
IPC 8 full level
C07D 233/72 (2006.01); C07D 235/02 (2006.01)
CPC (source: EP KR)
C07D 235/02 (2013.01 - EP KR)
Citation (examination)
- US 4181728 A 19800101 - BELLETIRE JOHN L [US], et al
- US 4117230 A 19780926 - SARGES REINHARD
- J. MED. CHEM., vol. 17, 1967, pages 957-959
Designated contracting state (EPC)
AT BE CH DE FR GB IT LI LU NL SE
DOCDB simple family (publication)
EP 0092385 A2 19831026; EP 0092385 A3 19850109; EP 0092385 B1 19910612; AU 1325983 A 19831020; AU 561264 B2 19870507; CA 1200247 A 19860204; DE 3382308 D1 19910718; ES 521444 A0 19840601; ES 8405375 A1 19840601; GR 78557 B 19840927; IE 56955 B1 19920212; IE 830837 L 19831015; IL 68314 A0 19830731; KR 840004408 A 19841015; KR 900003392 B1 19900518; NZ 203876 A 19851108; PT 76552 A 19830501; PT 76552 B 19860121; WO 8303543 A1 19831027
DOCDB simple family (application)
EP 83302111 A 19830414; AU 1325983 A 19830408; CA 425866 A 19830414; DE 3382308 T 19830414; ES 521444 A 19830414; GR 830171074 A 19830413; IE 83783 A 19830412; IL 6831483 A 19830406; KR 830001571 A 19830414; NZ 20387683 A 19830413; PT 7655283 A 19830414; US 8300546 W 19830411